KALION, INC.

Milton, MA · Founded 2010 · CIK 0001595918 · Biotech · Private

Genetically engineered E. coli strains and fermentation process for biobased production of glucaric acid from glucose

kalioninc.com →
Grants
$1.2M
3 awards
Sector median: 1
Raised
$6.7M
7 Form D · Nov 2023
35 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$747,308
Private capital raisedForm D · SEC$697,224
Federal grantNational Science Foundation · Phase I · STTR Phase I: Bioprocess-derived Glucaric Acid as a Renewable Feedstock for Diverse Polymers$225,000
Private capital raisedForm D · SEC$519,015
Federal grantNational Science Foundation · Phase I · STTR Phase I: Low-Cost, High-Purity Biobased Glucaric Acid$225,000
Private capital raisedForm D · SEC$2,999,970
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Low-Cost, High-Purity Biobased Glucaric Acid$746,822
Private capital raisedForm D · SEC$700,445
Private capital raisedForm D · SEC$640,804
Private capital raisedForm D · SEC$405,869
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2144Scinai Immunotherapeutics Ltd.—$3.0M
2145ISOLERE BIO INC——
2146Origin Life Sciences, Inc.—$2.9M
2147KALION, INC.—$6.7M
2148VIRONGY, LLC——
2149EpiBiologics, Inc.—$30M
2150Egalet Corp—$42M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Nada JainDirector
  • Kristala Jones PratherDirector
  • Melissa KentDirector
  • Robert MiniuttiDirector
  • Darcy PratherDirector · Executive Officer
  • Kristala PratherDirector · Executive Officer
  • Andrew ShaferDirector
  • Joan ZiefDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.